The project focuses on the social, technological and political/legal structures of the global market for biomedicines, the pharmaceutical products of the biotechnology industry. Access to these emerging medical technologies, largely developed in the North, is a major health and economic development issue that this project proposes to decipher around the issues of production, consumption and regulation covered by GRIP’s axis 3. The project consists of exploratory field surveys in two BRICS countries: South Africa and Brazil. These surveys complement research conducted in Cuba and India.